Contact Pathology

Search Catalog for Test or Protocol


Click here for search tips

Pathology Services Updates


NOVEL Tests

NOVEL TESTS FOR THERAPEUTIC DRUG MONITORING NOW AVAILABLE IN THE CLINICAL CHEMISTRY LABORATORY

Effective 1/29/2015, VORICONAZOLE (Anti-Fungal) AND EVEROLIMUS (Immunosuppressant) testing will be available using Quantitative Tandem Liquid Mass spectrometry in the Clinical Chemistry Laboratory.

VORICONAZOLE (Trough): Indications for Ordering: Therapeutic monitoring for individuals taking an antifungal drug (trough collection)

•Voriconazole is used in the treatment of

  • Candida spp
  • Aspergillus spp
  • Fusarium spp
  • Scedosporium

• Due to toxicity risk and need for optimal efficacy in patient therapy, all antifungal treatment should be monitored with trough levels

EVEROLIMUS
Indications for Ordering: Therapeutic monitoring for individuals taking everolimus
• Everolimus is used for prophylaxis of organ rejection in patients receiving a kidney and liver transplant.
• Everolimus is used in treatment of renal cell carcinoma
• Trough concentrations should be assessed ~2 weeks after beginning treatment

Testing will initially be offered on weekdays with a 24 hour TAT. All test requirements, therapeutic and toxic ranges are on the Pathology Online Catalog.


Please feel free to contact Dr. Devaraj at 832-826-1717 if you have any questions.

>see message history